— Know what they know.
Not Investment Advice
Also trades as: CRW.L (LSE) · $vol 4M

CRWRF OTC

Craneware plc
1W: +0.0% 1M: +0.0% 3M: -25.6% YTD: -31.6% 1Y: -47.1% 3Y: -6.6% 5Y: -43.3%
$18.00
+0.00 (+0.00%)
 
OTC · Healthcare · Medical - Healthcare Information Services · Tech Score Sell · Power 51 · $616.3M mcap · 27M float · 0.0006% daily turnover · Short 86% of daily vol
Smart Money Score
No convergence signal
Key Statistics
Market Cap$616.3M
52W Range15.23-32.07
Volume250
Avg Volume157
Beta-0.15
Dividend$0.42
Analyst Ratings
No analyst coverage
Company Info
CEOKeith Neilson
Employees747
SectorHealthcare
IndustryMedical - Healthcare Information Services
IPO Date2012-02-07
1 Tanfield
Edinburgh, SC EH3 5DA
GB
44 13 1550 3100
About Craneware plc

Craneware plc, alongside its various subsidiaries, is dedicated to developing, licensing, and providing ongoing support for specialized software solutions within the United States healthcare industry. The company's comprehensive suite of products addresses a wide range of operational and financial needs. For revenue cycle and financial management, Craneware offers Trisus pricing transparency software, designed to clarify pricing information, along with Trisus Pricing Analyzer to automate and simplify price modeling. Its Trisus Chargemaster provides automated management of chargemaster data, while InSight Audit assists government and commercial payors with audit processes. Additionally, InSight Denials facilitates the analysis, tracking, and reporting of claims denial data, and Trisus Claims Informatics offers retrospective analytical insights to identify charge capture risks. In the realm of clinical operations and supply chain, solutions include InSight Medical Necessity, which helps U.S. payors determine medical necessity; Trisus Supply, aimed at enhancing reimbursement for medical supplies; and Trisus Healthcare Intelligence, delivering patient-level insights into resource consumption. The portfolio also extends to Trisus Medication Analytic and Trisus Supplies Assistant solutions. Craneware also features a specialized line of pharmacy and drug tracking software. This includes Sentinel for drug tracking, Sentrex (a SaaS platform enabling covered entities to expand medication access), Sentrex 330, a Referral Verification System, and Sentry Core, which streamlines the complexities of pharmacy procurement, utilization, and compliance. Beyond its software offerings, Craneware provides professional and appeal services. The company was founded in 1999 and is headquartered in Edinburgh, United Kingdom.

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms